Celontin
Active substance: methsuximide
CAPSULE · METHSUXIMIDE 300 mg/1
United StatesActive
Marketing holder: Parke-Davis Div of Pfizer Inc
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- METHSUXIMIDE · 300 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12091-67e6-7117-b59b-46cc4d50915d,01a12092-889c-7ae4-be8b-adaed30dfe8b;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0071-0525
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0071-0525 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0071-0525 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0071-0525 · Verified 2026-10-09 · open in source